GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for probable dual-specificity RNA methyltransferase rlmn (A9NEU7)

Analyse AlphaFold monomer V2.0 prediction for probable dual-specificity RNA… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
A9NEU7
Type
protein
Length
338 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0xd10960F956646DE8b64d3598984c91C2d5Af3D7b
Molecule
Probable dual-specificity RNA methyltransferase rlmn
UniProt
A9NEU7
Pockets
2 · best druggability 0.79

Structure

1 distinct chain · 40% helix, 22% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProbable dual-specificity RNA methyltransferase rlmnprotein33840% helix, 22% strandA9NEU7

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14860.790.8662empty
2520.460.8512empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.